1-156378336-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_020407.5(RHBG):āc.610C>Gā(p.Gln204Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000167 in 1,613,754 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/14 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_020407.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RHBG | NM_020407.5 | c.610C>G | p.Gln204Glu | missense_variant | 4/10 | ENST00000537040.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RHBG | ENST00000537040.6 | c.610C>G | p.Gln204Glu | missense_variant | 4/10 | 1 | NM_020407.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152190Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000281 AC: 7AN: 248828Hom.: 0 AF XY: 0.0000370 AC XY: 5AN XY: 135002
GnomAD4 exome AF: 0.00000958 AC: 14AN: 1461446Hom.: 0 Cov.: 34 AF XY: 0.00000963 AC XY: 7AN XY: 727040
GnomAD4 genome AF: 0.0000854 AC: 13AN: 152308Hom.: 0 Cov.: 31 AF XY: 0.0000940 AC XY: 7AN XY: 74470
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 23, 2024 | The c.610C>G (p.Q204E) alteration is located in exon 4 (coding exon 4) of the RHBG gene. This alteration results from a C to G substitution at nucleotide position 610, causing the glutamine (Q) at amino acid position 204 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at